title: Acute hyperglycemia is related to gastrointestinal symptoms in motion sickness: an experimental study.
abstract: Motion sickness is caused by exposure to unfamiliar motions and typical symptoms of motion sickness include nausea and vomiting. To observe the metabolic and hormonal differences between nausea/vomiting (NAV) subjects and non-nausea/vomiting (NNV) ones, and to understand how the differences in metabolites and hormones affect the tolerance of organism to acceleration, 60 volunteers were exposed to repetitive acceleration using a 6-degree-of-freedom ship motion simulator. Meanwhile, 36 rats were randomly divided into three groups: an acceleration model group (n=14, exposed to acceleration), insulin group (n=14, intraperitoneal injection of insulin 30 min before exposure to acceleration), and control group (n=8). Gas chromatography coupled to time-of-flight mass spectrometry (GC-TOF/MS) was applied to analyze the serum metabolites in human subjects. Serum glucocorticoid, insulin, and glucagon levels were determined by radioimmunoassay in the NAV and NNV subjects as well as in rats, and serum epinephrine level was determined by ELISA. After acceleration exposure, 9 metabolites, including L-histidine, L-ornithine, L-serine, L-tyrosine, pyroglutamic acid, fumaric acid, urea, n-dodecanoic acid and n-tetradecanoic acid, had different changes in the NAV and NNV groups. The serum levels of 4-hydroxy-L-proline, glucose, oleic acid and urea were significantly higher in the NAV group than in the NNV group after exposure; however, only the elevation degree of serum glucose was significantly greater in the NAV group than in the NNV group (P<0.05). Serum cortisol and epinephrine were increased in both groups. Before exposure, insulin level in the NAV group was significantly lower than that in the NNV group (P<0.05). After rotation exposure, rat serum glucose in the insulin group was significantly lower than that in the acceleration model group (P<0.001), and the motion sickness index was significantly lower than that in the acceleration model group (P<0.05). Our study provides the first evidence that stable glucose level can help to relieve gastrointestinal symptoms in motion sickness, and suggests that acute hyperglycemia is related to gastrointestinal symptoms in motion sickness.
authors: Department of Military Hygiene, Faculty of Navy Medicine, Second Military Medical University, Shanghai 200433, China.
authors: Feng-Feng
authors: FF
authors: Mo
authors: Hai-Hong
authors: HH
authors: Qin
authors: Xiao-Li
authors: XL
authors: Wang
authors: Zhi-Lei
authors: ZL
authors: Shen
authors: Zheng
authors: Z
authors: Xu
authors: Kai-Hua
authors: KH
authors: Wang
authors: Yi-Ling
authors: YL
authors: Cai
authors: Min
authors: M
authors: Li
mesh_terms: D000054:Acceleration / Q000009:adverse effects; D000818:Animals; D001786:Blood Glucose; D004195:Disease Models, Animal; D005767:Gastrointestinal Diseases / Q000209:etiology*; D006728:Hormones / Q000097:blood; D006801:Humans; D006854:Hydrocortisone; D006943:Hyperglycemia / Q000150:complications* / Q000209:etiology*; D008297:Male; D009041:Motion Sickness / Q000097:blood / Q000150:complications* / Q000209:etiology; D025341:Principal Component Analysis; D011863:Radioimmunoassay; D051381:Rats; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D006728:Hormones; D006854:Hydrocortisone